Related Experiment Video
Updated: Mar 24, 2026
07:32
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
2.1K
[Hemophagocytic syndrome: problems in diagnosis]
1Division of Clinical Hematology/Immunology, Kumamoto City Hospital.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|November 7, 2000
Summary
Hemophagocytic syndrome (HPS) involves fever, low blood counts, and liver issues due to an overactive immune response. Diagnosing its various forms, triggered by different factors, presents significant challenges.
Area of Science:
- Immunology
- Hematology
- Pathology
Context:
- Hemophagocytic syndrome (HPS) is a life-threatening condition.
- Characterized by fever, pancytopenia, liver dysfunction, and histiocyte proliferation with hemophagocytosis.
- Caused by excessive cytokine production from activated T cells and macrophages.
Purpose:
- To provide an overview of Hemophagocytic syndrome (HPS).
- To highlight the diagnostic challenges associated with HPS.
- To discuss the classification and sub-entities of HPS.
Summary:
- HPS presents with distinct clinical and pathological features.
- It is classified into primary (hereditary) and secondary forms.
- Secondary HPS is further categorized by triggers and associated diseases, complicating diagnosis.
Impact:
- Understanding HPS is crucial for timely diagnosis and management.
- Recognizing the diagnostic difficulties can guide clinical practice.
- This overview aids researchers and clinicians in navigating the complexities of HPS sub-types.
